Vertex to buy Crinetics in $10 billion deal
Vertex to buy Crinetics in $10 billion deal July 6 (Reuters) - Vertex Pharmaceuticals VRTX.O will buy Crinetics Pharmaceuticals CRNX.O for a total equity value of about $10 billion, the companies said on Monday.
(Reporting by Puyaan Singh in Bengaluru; Editing by Jonathan Ananda)
Recent news on Crinetics Pharmaceuticals
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Crinetics Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Crinetics Q2 revenue jumps on PALSONIFY launch, withdraws guidance
Brief: Crinetics Pharmaceuticals Q2 Net Income USD -120.855 Million